MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Turmeric compound tested to stall cancer in High-Risk patients
Disease control CompletedThis pilot study tested whether a daily supplement of curcumin (from turmeric) and piperine (from black pepper) could slow or stop disease progression in 30 patients with early-stage prostate cancer, MGUS, or low-risk smoldering multiple myeloma. Participants took the supplement …
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New scans may catch bone marrow cancer earlier
Knowledge-focused CompletedThis study looked at whether newer imaging scans can better detect when early blood disorders (MGUS and smoldering myeloma) turn into active multiple myeloma. Thirty-one adults with these conditions received three types of scans to compare their results. The goal was to improve m…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC